Andere talen Shanghai Kehua Bio-Engineering Co.,Ltd

Aandelen

002022

CNE000001KC9

slotkoers Shenzhen S.E. Andere beurzen 00:00:00 30-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
7,36 ^CNY	+0,68%		+4,69%	-35,33%

28/04	Shanghai Kehua Bio-Engineering Co.,Ltd rapporteert resultaten voor het eerste kwartaal eindigend op 31 maart 2024	CI
22/03	Shanghai Kehua Bio-Engineering Co.,Ltd rapporteert resultaten voor het volledige jaar eindigend op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	28/04
Kehua Bio-Engineering Gets Registration Certificates for Two Devices	15/04
Tranche Update on Shanghai Kehua Bio-Engineering Co.,Ltd's Equity Buyback Plan announced on October 29, 2023.	02/04
Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	22/03
Shanghai Kehua Bio-Engineering Co.,Ltd Approves Board Elections	21/03
Kehua Bio-Engineering Gets Nod to Register Protein Detection Kit	05/03
Xi'an Zhitong Benyi Enterprise Management Partnership Enterprise (Limited Partnership) completed the acquisition of 5% stake in Shanghai Kehua Bio-Engineering Co.,Ltd from Zhuhai Baolian Asset Management Co., Ltd.	29/02
Shanghai Kehua Bio-Engineering Gets Approval for Leucine Aminopeptidase Kit	19/02
Xi'an Zhitong Benyi Enterprise Management Partnership Enterprise (Limited Partnership) agreed to acquire 5% stake in Shanghai Kehua Bio-Engineering Co.,Ltd from Zhuhai Baolian Asset Management Co., Ltd. for CNY 514.3 million.	12/01
Tranche Update on Shanghai Kehua Bio-Engineering Co.,Ltd's Equity Buyback Plan announced on October 29, 2023.	02/01
Shanghai Kehua Bio-Engineering Co.,Ltd announces an Equity Buyback for CNY 200 million worth of its shares.	29-10-23
Shanghai Kehua Bio-Engineering Co.,Ltd authorizes a Buyback Plan.	27-10-23
Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	27-10-23
KHB Becomes First Chinese Company to Obtain EU Class D IVDR Certification for Its Rapid Test HIV Colloidal Gold Diagnostic Kit	11-10-23
Shanghai Kehua Bio-Engineering Co.,Ltd(XSEC:002022) added to S&P Global BMI Index	18-09-23
Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	16-08-23
Shanghai Kehua Bio-Engineering Registers Hepatitis Detection Kit	14-08-23
Shanghai Kehua Bio-Engineering Co.,Ltd Approves Management Appointments	29-06-23
Kehua Bio-Engineering Registers Diagnostic Reagent	22-06-23
Shanghai Kehua Bio-Engineering Co.,Ltd Approves Cash Dividend for the Year 2022, Payable on 10 May 2023	28-04-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Shanghai Kehua Bio-Engineering Co.,Ltd

Aandelen

002022

CNE000001KC9

Andere talen

Filters